Adverum Biotechnologies
ADVM
$8.04
Share price
-2.55%
Change (1 day)
957.89%
Change (1 year)
EPS for Adverum Biotechnologies (ADVM)
EPS in 2023 (TTM): -$1.33
According to Adverum Biotechnologies 's latest financial reports the company's current EPS (TTM) is -$1.33. In 2022 the company made an earnings per share (EPS) of -$1.55 a decrease over its 2021 EPS that were of -$1.48.
EPS history for Adverum Biotechnologies from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$1.33 | -14.19% |
| 2022 | -$1.55 | 4.73% |
| 2021 | -$1.48 | 8.03% |
| 2020 | -$1.37 | 35.64% |
| 2019 | -$1.01 | -14.41% |
| 2018 | -$1.18 | -8.53% |
| 2017 | -$1.29 | -59.94% |
| 2016 | -$3.22 | 73.58% |
| 2015 | -$1.86 | 29.06% |
| 2014 | -$1.44 | 465.99% |
| 2013 | -$0.25 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | 63.91% | 🇺🇸 USA |